# Paragon Biosciences Evozyne Capital, LLC — Form D

Paragon Biosciences Evozyne Capital, LLC of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-07. The offering totals $9.5M, of which $9.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-05-07
- Form: D
- Accession: 0001811339-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.5M
- Amount sold: $9.5M
- Investors: 2
- Date of first sale: 2020-04-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-366520

## Issuer

- Name: Paragon Biosciences Evozyne Capital, LLC
- CIK: 0001811339
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 330 N. WABASH AVENUE, CHICAGO, IL, 60611
- Phone: 312-847-1322

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Patrick J Morris | Director | Chicago, IL |
| Patrick J Morris | Executive Officer | Chicago, IL |
| Darien J Parhad | Executive Officer | Chicago, IL |

## More

- [CIK 1811339 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1811339&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001811339-20-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.